Gene · 10963
Papers2,196
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,196
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| AKT1 phosphorylates PRMT7 to promote GLUD1 methylation and gastric cancer progression. | Cell Death Dis | 2026 | 41876450 | PubTator, text mining | PubMed |
| ALS mutations disrupt self-association between the ubiquilin STI1 hydrophobic groove and internal placeholder sequences. | EMBO J | 2026 | 41862640 | PubTator, text mining | PubMed |
| Nanoparticles-based phototherapy systems: molecular mechanisms and clinical applications. | Signal Transduct Target Ther | 2026 | 41839827 | PubTator, text mining | PubMed |
| Succinylation: novel molecular mechanisms and prospects for targeted therapy in liver diseases. | Front Mol Biosci | 2026 | 41788628 | PubTator, text mining | PubMed |
| Synaptic Chaperone Dysfunction as a Convergent Mechanism in Neurodegenerative and Psychiatric Disorders. | Neurosci Insights | 2026 | 41783689 | PubTator, text mining | PubMed |
| Functions of J-domain proteins in mitochondrial protein biogenesis. | Protein Sci | 2026 | 41772814 | PubTator, text mining | PubMed |
| Heat shock proteins (Hsp70 and Hsp90) in neurodegeneration: pathogenic roles and therapeutic potential. | Front Aging Neurosci | 2026 | 41767843 | PubTator, text mining | PubMed |
| From Genetic Determinism to Epigenetic Regulation: Paradigm Shifts in the Understanding of Neurodevelopmental Disorders. | Curr Issues Mol Biol | 2026 | 41751429 | PubTator, text mining | PubMed |
| Evolutionary remodeling of a remnant GET pathway factor into PEX38, an essential peroxin. | Proc Natl Acad Sci U S A | 2026 | 41746722 | PubTator, text mining | PubMed |
| RNA-Seq of Gingival Fibroblasts Grown on Collagen Membranes and Hyaluronic Acid. | J Funct Biomater | 2026 | 41745519 | PubTator, text mining | PubMed |
| Enzymes that generate and regulate intracellular persulfides and polysulfides: mechanistic insights and inhibitors. | Front Physiol | 2026 | 41736950 | PubTator, text mining | PubMed |
| Targeting Hsp70 triggers ferroptosis: a novel anti-cancer mechanism of a marine natural product in prostate cancer. | Nat Prod Bioprospect | 2026 | 41639515 | PubTator, text mining | PubMed |
| Molecular Mechanisms and Therapeutic Potential of Degron-Mediated Proteostasis Regulation in Neurodegenerative Diseases. | Cell Mol Neurobiol | 2026 | 41528540 | PubTator, text mining | PubMed |
| An electrochemical biosensing platform based on α‑iron trioxide/ferriferrous oxide magnetic nanocomposites for early diagnosis of hepatocellular carcinoma. | Bioelectrochemistry | 2026 | 41406518 | PubTator, text mining | PubMed |
| Tropomyosin-1 positively regulates TGF-β/Smad3 signaling through STUB1 in arecoline-induced oral submucosal fibrosis. | Odontology | 2026 | 41203971 | PubTator, text mining | PubMed |
| The possibilities and challenges associated with selective targeting Plasmodium falciparum Hsp90 for Malaria. | Trans R Soc S Afr | 2025 | 41836916 | PubTator, text mining | PubMed |
| Age-varying DNA methylation patterns associated with blood pressure across the lifespan. | bioRxiv | 2025 | 41427279 | PubTator, text mining | PubMed |
| STIP1 drives Metabolic Reprogramming in Esophageal Squamous Cell Carcinoma via AHCY-LDHA Axis. | Exploration (Beijing) | 2025 | 41163796 | PubTator, text mining | PubMed |
| Ubiquilin-2 liquid droplets catalyze α-synuclein fibril formation. | EMBO J | 2025 | 41087580 | PubTator, text mining | PubMed |
| PDLIM4 drives gastric cancer malignant progression and cisplatin resistance by inhibiting HSP70 ubiquitination and degradation via competitive interaction with STUB1. | J Nanobiotechnology | 2025 | 41076533 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10963/papers?page=2